Skip to main content
SpringerLink
Log in

Drugs as tools in research on adrenoceptors

  • Rudolf Buchheim Lecture
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600

    Google Scholar 

  • Andén NE, Corrodi H, Fuxe K, Hökfelt T, Rydin C, Svensson T (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9:513–523

    Google Scholar 

  • Berthelsen S, Pettinger WA (1977) A functional basis for classification of adrenergic receptors. Life Sci 21:595–606

    Google Scholar 

  • Boissier JR, Giudicelli JF, Fichelle J, Schmitt H, Schmitt H (1968) Cardiovascular effects of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155). 1. Peripheral sympathetic system. Eur J Pharmacol 2:333–339

    Google Scholar 

  • Cavero I, Lefèvre-Borg F, Roach AG, Gomeni R, Scatton B (1982) Functional and biochemical evidence for the lack of cardiac presynaptic α 2-adrenoceptor stimulant properties of cirazoline (LD 3098), a potent α 1-adrenoceptor agonist in dogs and rats. J Pharmacol Exp Ther 223:241–250

    Google Scholar 

  • Constantine JW, McShane WK (1968) Analysis of the cardiovascular effects of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (catapresan). Eur J Pharmacol 4:109–123

    Google Scholar 

  • Docherty JR (1984) An investigation of presynaptic α-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens. Br J Pharmacol 82:15–23

    Google Scholar 

  • Doxey JC, Smith CFC, Walker JM (1977) Selectivity of blocking agents for pre- and postsynaptic α-adrenoceptors. Br J Pharmacol 60:91–96

    Google Scholar 

  • Folkow B, Neil E (1971) Circulation. University Press, New York Oxford

    Google Scholar 

  • Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. IV. The distribution of monoamine terminals in central nervous system. Acta Physiol Scand 64 Suppl 247:37–85

    Google Scholar 

  • Glusa E, Markwardt F, Barthel W (1979) Studies on the inhibition of adrenaline-induced aggregation of blood platelets. Pharmacology 19:196–201

    Google Scholar 

  • Glusa E, Markwardt E (1983) Characterization of postjunctional α-adrenoceptors in isolated human femoral veins and arteries. Naunyn-Schmiedeberg's Arch Pharmacol 323:101–105

    Google Scholar 

  • Hammer R, Kobinger W, Pichler L (1980) Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain α-adrenoceptors and relation to cardiovascular effects. Eur J Pharmacol 62:277–285

    Google Scholar 

  • Heller H (1933) Über die zentrale Blutdruckwirkung des Adrenalins. Naunyn-Schmiedeberg's Arch Pharmacol 173:291–300

    Google Scholar 

  • Henning M, van Zwieten PA (1967) Central hypotensive effect of α-methyl-DOPA. J Pharmacol 19:403–405

    Google Scholar 

  • Henning M, van Zwieten PA (1968) Central hypotensive action of α-methyl-DOPA. J Pharm Pharmacol 20:409–417

    Google Scholar 

  • Hoefke W, Kobinger W, Walland A (1975) Relationship between activity and structure in derivatives of clonidine. Arzneim Forsch 25:786–793

    Google Scholar 

  • Hoyer J, van Zwieten PA (1971) The centrally induced fall in blood pressure after the infusion of amphetamine and related drugs into the vertebral artery of the cat. J Pharm Pharmacol 23:892–893

    Google Scholar 

  • Hoyer J, van Zwieten PA (1972) The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine. J Pharm Pharmacol 24:452–458

    Google Scholar 

  • Hsu CY, Knapp DR, Halushka PV (1979) The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther 208:366–370

    Google Scholar 

  • Hudgins PM, Fleming WW (1966) A relative nonspecific supersensitivity in aortic strips resulting from pretreatment with reserpine. J Pharmacol Exp Ther 153:70–80

    Google Scholar 

  • Hukuhara T Jr, Otsuka Y, Takeda R, Sakai F (1968) Die zentralen Wirkungen des 2-(2,6-dichlorphenylamino)-2-imidazoline Hydrochlorides. Arzneim Forsch 18:1147–1153

    Google Scholar 

  • De Jonge A, van Meel JCA, Timmermans PBMWM, van Zwieten PA (1981) A lipophilic, selective α 2-adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587). Life Sci 28:2009–2016

    Google Scholar 

  • Klupp H, Knappen F, Otsuka Y, Streller J, Teichmann H (1970) Effects of clonidine on central sympathetic tone. Eur J Pharmacol 10:225–229

    Google Scholar 

  • Kobinger W (1967) Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiedeberg's Arch Pharmacol 258:48–58

    Google Scholar 

  • Kobinger W (1974) Medicinal chemistry related to the central regulation of blood pressure. II. Pharmacological part. In: Mass, J (ed) Medicinal Chemistry IV. Amsterdam-Oxford-New York: Elsevier Scientific Publishing, pp 107–120

    Google Scholar 

  • Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:40–100

    Google Scholar 

  • Kobinger W (1984 a) New concepts on α-adrenoceptors in pharmacology. J Pharmacol (Paris) suppl I:5–22

    Google Scholar 

  • Kobinger W (1984 b) Central antihypertensives. In: Parnham MJ, Bruinvels J (eds) Discoveries in Pharmacology, vol 2. Elsevier Biomedical Press, Amsterdam, pp 107–123

    Google Scholar 

  • Kobinger W, Pichler L (1974) Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine. Eur J Pharmacol 27:151–154

    Google Scholar 

  • Kobinger W, Pichler L (1975) Investigation into some imidazoline compounds, with respect to peripheral α-adrenoceptor stimulation and depression of cardiovascular centers. Naunyn-Schmiedeberg's Arch Pharmacol 291:175–191

    Google Scholar 

  • Kobinger W, Pichler L (1976) Centrally induced reduction in sympathetic tone-a postsynaptic α-adrenoceptor stimulating action of imidazolines. Eur J Pharmacol 40:311–320

    Google Scholar 

  • Kobinger W, Pichler L (1977) Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepin dihydrochloride) as a hypotensive agent of the “clonidine-type”. Naunyn-Schmiedeberg's Arch Pharmacol 300:39–46

    Google Scholar 

  • Kobinger W, Pichler L (1978) Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses. Clin Exp Hypertension 1:229–249

    Google Scholar 

  • Kobinger W, Pichler L (1980) Investigation into different types of post- and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402

    Google Scholar 

  • Kobinger W, Pichler L (1981 a) 122-4 subtypes: selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol 73:313–321

    Google Scholar 

  • Kobinger W, Pichler L (1981 b) 122-5 agonistic effect of B-HT 920 in isolated perfused hindquarters of rats. Eur J Pharmacol 76:101–105

    Google Scholar 

  • Kobinger W, Pichler L (1982a) α-Adrenoceptor subtypes in cardiovascular regulation. J Cardiovasc Pharmacol 4:81–85

    Google Scholar 

  • Kobinger W, Pichler L (1982b) Presynaptic activity of the imidazolidine derivative St 587, a highly selective α 2-adrenoceptor agonist. Eur J Pharmacol 82:203–206

    Google Scholar 

  • Kobinger W, Pichler L (1983 a) Subgroups of α-adrenoceptors: Selectivity of drugs and receptor importance in various target system. Arzneim Forsch 28. Beiheft: 83–91

    Google Scholar 

  • Kobinger W, Pichler L (1983 a) 122-7 Selectivity ratio in a series of agonists and their relation to pre/postsynaptic activity ratios. Eur J Pharmacol 91:129–133

    Google Scholar 

  • Kobinger W, Walland A (1967 a) Kreislaufuntersuchungen mit 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride. Arzneim Forsch 17:292–300

    Google Scholar 

  • Kobinger W, Walland A (1967 b) Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline HCl. Eur J Pharmacol 2:155–162

    Google Scholar 

  • Kobinger W, Walland A (1971) Involvement of adrenergic receptors in central vagus activity. Eur J Pharmacol 16:120–122

    Google Scholar 

  • Kobinger W, Walland A (1972 a) Evidence for a central activation of a vagal cardiodepressor reflex by clonidine. Eur J Pharmacol 19:203–209

    Google Scholar 

  • Kobinger W, Walland A (1972 b) Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptors. Eur J Pharmacol 19:210–217

    Google Scholar 

  • Kobinger W, Lillie C, Pichler L (1980) Central cardiovascular α-adrenoceptors. Relation to peripheral receptors. Circ Res 46 Suppl I: I21-I25

    Google Scholar 

  • Konzett H (1981) On the discovery of isoprenaline. Trends in Pharmacol Sciences 2:47–49

    Google Scholar 

  • Korner PJ, Oliver JR, Sleight P, Chalmers JP, Robinson JS (1974) Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic fibre discharge. Eur J Pharmacol 28:189–198

    Google Scholar 

  • Korner PI, Head GA (1981) Effects of noradrenergic and serotonergic neurons on blood pressure, heart rate and the baroreceptor-heart rate reflex of the conscious rabbit. J Autonom Nerv Syst 3:511–523

    Google Scholar 

  • Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1773–1800

    Google Scholar 

  • Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481–497

    Google Scholar 

  • Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

    Google Scholar 

  • Lues I, Schümann HJ (1984) B-HT 920 acts as an α 2-adrenoceptor agonist in the rabbit aorta under certain in vitro conditions. Naunyn-Schmiedeberg's Arch Pharmacol 325:42–46

    Google Scholar 

  • DeMey JG, Vanhoutte PM (1980) Differences in pharmacological properties of postjunctional alpha-adrenergic receptors among arteries and veins. Arch Int Pharmacodyn 244:328–329

    Google Scholar 

  • McCubbin JW, Kaneko Y, Page IH (1960) Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ Res 8:849–858

    Google Scholar 

  • Van Meel JCA, de Jonge A, Timmermans PBMWM, van Zwieten PA (1981) Selectivity of some α-adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 219:760–767

    Google Scholar 

  • Van Meel JCA, Timmermans PBMWM, van Zwieten PA (1983) 123-2 stimulation in the isolated perfused hindquarters of the rat: an in vitro model. J Cardiovas Pharmacol 5:580–585

    Google Scholar 

  • Pichler L, Kobinger W (1981) Centrally mediated cardiovascular effects of B-HT 920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine dihydrochloride), a hypotensive agent of the “clonidine type”. J Cardiovasc Pharmacol 3:269–277

    Google Scholar 

  • Sattler RW, van Zwieten PA (1967) Acute hypotensive action of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur J Pharmacol 2:9–13

    Google Scholar 

  • Schmitt H (1977) The pharmacology of clonidine and related products. In: Gross F (ed) Handbook of experimental pharmacology, vol 39, Antihypertensive drugs. Springer, Berlin Heidelberg New York, pp 299–396

    Google Scholar 

  • Schmitt H, Schmitt H, Boissier JR, Giudicelli JF (1967) Centrally mediated decrease in sympathetic tone induced by 2-(2,6-dichlorphenylamino)-2-imidazoline (St 155, catapresan). Eur J Pharmacol 2:147–148

    Google Scholar 

  • Schmitt H, Schmitt H, Boissier JR, Giudicelli JF, Fichelle J (1968) Cardiovascular effects of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (St 155). II. Central sympathetic structures. Eur J Pharmacol 2:340–346

    Google Scholar 

  • Schmitt H, Schmitt H, Fenard S (1971) Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol 14:98–100

    Google Scholar 

  • Schmitt H, Schmitt H, Fenard S (1973) Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneim Forsch 23:40–45

    Google Scholar 

  • Schümann HJ, Lues I (1983) Postjunctional α-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin. Naunyn-Schmiedeberg's Arch Pharmacol 323:328–334

    Google Scholar 

  • Sherman GP, Grega GJ, Woods RJ, Buckley JP (1969) Evidence for a central hypotensive mechanism of 2-(2,6-dichlorphenylamino)-2-imidazoline (catapresan, St 155). Eur J Pharmacol 2:326–328

    Google Scholar 

  • Stähle H (1982) Clonidine. In: Bindra JS, Lednicer D (s) Chronicles of drug discovery, vol 1. Wiley, New York, p 87

    Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    Google Scholar 

  • Starke K (1981) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–236

    Google Scholar 

  • Starke K, Endo T, Taube HD (1975) Relative pre- and post-synaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78

    Google Scholar 

  • Starke K, Langer SZ (1979) A note on terminology for presynaptic receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors/Advances in the biosciences, vol 18 Pergamon Press, Oxford New York Toronto Sydney Paris Frankfurt, pp 1–3

    Google Scholar 

  • Starke K, Montel H (1973) Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurons. Neuropharmacol 12:1073–1080

    Google Scholar 

  • Strömbom U (1976) Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 292:167–176

    Google Scholar 

  • Svensson TH, Bunney BS, Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92:291–306

    Google Scholar 

  • Timmermans PBMWM, van Zwieten PA (1977) Central and peripheral α-adrenergic effects of some imidazolidines. Eur J Pharmacol 45:229–236

    Google Scholar 

  • Timmermans PBMWM, van Zwieten PA (1980) Postsynaptic α 1 and α 2-adrenoceptor in the circulatory system of the pithed rat. Selective stimulation of the α2-Type by B-HT 933. Eur J Pharmacol 63:199–202

    Google Scholar 

  • Timmermans PBMWM, van Zwieten PA (1981) Correlations between central hypotensive and peripheral hypertensive effects of structurally dissimilar alpha-adrenoceptor agonists. Life Sciences 28:653–660

    Google Scholar 

  • Timmermans PBMWM, Hoefke W, Stähle H, van Zwieten PA (1980) Structure-activity relationship in clonidine-like imidazolidines and related compounds. Progr Pharmacol 3:1–104

    Google Scholar 

  • Uchida W, Kimura T, Satoh S (1984) Presence of presynaptic inhibitory α1-adrenoceptors in the cardiac sympathetic nerves of the dog: effects of prazosin and yohimbine on sympathetic neurotransmission to the heart. Eur J Pharmacol 103:51–56

    Google Scholar 

  • Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 82, Suppl 367:1–48

    Google Scholar 

  • Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:127–136

    Google Scholar 

  • Wikberg J (1978) Differentiation between pre- and post-junctional α-receptors in guinea pig ileum and rabbit aorta. Acta Physiol Scand 103:225–239

    Google Scholar 

  • Wikberg JES (1979) The pharmacological classification of adrenergic α1 and α2 receptors and their mechanisms of action. Acta Physiol Scand 106, Suppl 468:1–99

    Google Scholar 

  • Van Zwieten PA (1975) Antihypertensive drugs with a central action. Prog Pharmacol 1:1–63

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacological Department, Ernst-Boehringer-Institute, Dr. Boehringer-Gasse 5-11, A-1121, Vienna, Austria

    W. Kobinger

Authors
  1. W. Kobinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The second Rudolf-Buchheim-Lecture was given on September 21, 1982, on the occasion of the Autumn Meeting of the German Pharmacological Society in Vienna. As there was a considerable time interval between the lecture and the editors' invitation, the editors encouraged the author to update the lecture

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobinger, W. Drugs as tools in research on adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 113–123 (1986). https://doi.org/10.1007/BF00511400

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00511400

Search

Navigation